The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Hameln Pharma Pty Ltd

Regulatory activities for this sponsor.

14 result(s) found, displaying 11 to 14

OXYCODONE-HAMELN oxycodone hydrochloride 20 mg/2 mL injection solution ampoule (343479)

7 October 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OXYCODONE-HAMELN oxycodone hydrochloride 20 mg/2 mL injection solution ampoule.
EPHEDRINE-HAMELN (Hameln Pharma Pty Ltd)

24 December 2021

Prescription medicine registration

Active ingredients: ephedrine hydrochloride.
OXYCODONE-HAMELN (Hameln Pharma Pty Ltd)

2 July 2021

Prescription medicine registration

Active ingredients: oxycodone hydrochloride.
HYDROMORPHONE-HAMELN; HYDROMORPHONE-HAMELN-HP (Hameln Pharma Pty Ltd)

17 June 2021

Prescription medicine registration

Active ingredients: hydromorphone hydrochloride.